Human medicines European public assessment report (EPAR): Tolucombi, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 24 June 2025 - 13:19

Human medicines European public assessment report (EPAR): Tolucombi, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 12, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Namuscla, Mexiletine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0227/2024

Submitted by Anonymous (not verified) on 24 June 2025 - 13:18

Opinion/decision on a Paediatric investigation plan (PIP): Namuscla, Mexiletine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0227/2024

Public event: advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)

Submitted by Anonymous (not verified) on 24 June 2025 - 9:23

Public event: advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness